Analysts Give Doximity a 6.5/10: 3 Things to Watch

Analysts rate Doximity 6.5/10 and see cautious optimism amid AI-driven disruption risk.
This episode breaks down business strength, management, financials, valuation, and the key metrics investors should monitor.
– Why Doximity is a sticky, niche network for medical professionals and where its moat may be vulnerable.
– Management track record since the 2021 IPO: revenue growth, margin expansion, and rising free cash flow.
– Financial health and valuation context: ~14x free cash flow and ~18x earnings relative to decelerating growth.
– Primary risk from AI lowering barriers to entry and the importance of integrating AI features.
– What investors should watch next: revenue growth, free cash flow trajectory, AI adoption, churn, and R&D milestones.
————————————————————————
This video is brought to you by The Motley Fool.
Visit https://fool.com/Invest to get access to this special offer. The Motley Fool Stock Advisor returns are 993% as of 5/18/2026 and measured against the S&P 500 returns of 207% as of 5/18/2026. Past performance is not an indicator of future results. All investing involves a risk of loss. Individual investment results may vary, not all Motley Fool Stock Advisor picks have performed as well.
————————————————————————